{"id":"W4310161038","doi":"10.1182/blood-2022-158011","title":"Once Weekly Selinexor, Carfilzomib and Dexamethasone (XKd) in Triple Class Refractory Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; CancerCare Manitoba; Vancouver General Hospital; University of Calgary; Dalhousie University; University of Alberta; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Daratumumab; Tolerability; Refractory (planetary science); Regimen; Dexamethasone; Internal medicine; Population; Multiple myeloma; Oncology; Proteasome inhibitor; Pharmacology; Adverse effect; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003761323,0.0002392989,0.0006036636,0.000262707,0.0002252007,0.0002916555,0.0002195469,0.0003573472,0.0009530204],"category_scores_gemma":[0.0003241573,0.00008687883,0.000332946,0.0002617417,0.0001831579,0.0002341267,0.0002239579,0.0005734934,0.0002171258],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000518602,"about_ca_system_score_gemma":0.0003974614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008366944,"about_ca_topic_score_gemma":0.003052427,"domain_scores_codex":[0.9998846,0.00003091052,0.00001633375,0.00002097903,0.00002348102,0.00002370867],"domain_scores_gemma":[0.9998193,0.00003418132,0.00004234018,0.000007397999,0.000008975539,0.00008791347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.05968113,0.00327582,0.06013815,0.001516298,0.0009619322,0.005654008,0.0004412408,0.002397893,0.03246029,0.0004645228,0.006708962,0.8262998],"study_design_scores_gemma":[0.05175366,0.183385,0.6084244,0.001081883,0.002435434,0.04497882,0.0007983378,0.007844167,0.01911361,0.00171535,0.07833562,0.000133714],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9700931,0.0255815,0.0002539626,0.001109662,0.0001107849,0.0001180028,0.0001834194,0.00004899776,0.002500519],"genre_scores_gemma":[0.9933223,0.00518524,0.0002485854,0.0003545315,0.00007122565,0.00003346203,0.0001882894,0.000003382502,0.000592924],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009530204,"threshold_uncertainty_score":0.003762782,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02735146881473767,"score_gpt":0.28865458530026,"score_spread":0.2613031164855223,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}